Kimia Sobhani
Overview
Explore the profile of Kimia Sobhani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Figueiredo J, Levy J, Choi S, Xu A, Merin N, Hamid O, et al.
iScience
. 2024 Sep;
27(9):110596.
PMID: 39286512
Patients with cancer are at increased risk of death from COVID-19 and have reduced immune responses to SARS-CoV2 vaccines, necessitating regular boosters. We performed comprehensive chart reviews, surveys of patients...
2.
Ebinger J, Sun N, Joung S, Sanchez J, Wang M, Liu Y, et al.
J Infect Dis
. 2024 May;
230(3):e584-e590.
PMID: 38717928
Background: The extent to which infection versus vaccination has conferred similarly durable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity during the Omicron era remains unclear. Methods: In a cohort...
3.
Mastali M, Asif A, Fu Q, Wei J, Korley F, Peacock W, et al.
Am Heart J Plus
. 2024 Apr;
13:100110.
PMID: 38560066
Background: Associations between elevated circulating cardiac troponin I (cTnI) levels and adverse cardiac outcomes were established prior to the ability to measure extremely low levels of cTnI. Immunoassays that achieve...
4.
Moradian A, Goonatilleke E, Lin T, Hatten-Beck M, Emrick M, Schepmoes A, et al.
Clin Chem
. 2024 Mar;
70(6):855-864.
PMID: 38549041
Background: The enhanced precision and selectivity of liquid chromatography-tandem mass spectrometry (LC-MS/MS) makes it an attractive alternative to certain clinical immunoassays. Easily transferrable work flows could help facilitate harmonization and...
5.
Sobhani K, Cheng S, Binder R, Mantis N, Crawford J, Okoye N, et al.
Vaccines (Basel)
. 2023 Nov;
11(11).
PMID: 38005976
Herein, we review established clinical use cases for SARS-CoV-2 antibody measures, which include diagnosis of recent prior infection, isolating high titer convalescent plasma, diagnosing multisystem inflammatory syndrome in children (MIS-C),...
6.
Figueiredo J, Levy J, Choi S, Xu A, Merin N, Hamid O, et al.
medRxiv
. 2023 Nov;
PMID: 37961284
Highlights: COVID-19 booster vaccinations increase antibody levels and maintain T-cell responses against SARS-CoV-2 in patients receiving various anti-cancer therapiesBooster vaccinations reduced all-cause mortality in patientsA significant proportion of patients remain...
7.
Jordan S, Joung S, Wang M, Tran T, Bravo M, Masoom H, et al.
Transpl Infect Dis
. 2023 Oct;
26(1):e14182.
PMID: 37885435
Background: Tixagevimab-cilgavimab (Tix-Cil) was authorized for prophylaxis against COVID-19 in immunocompromised patients from December 2021 through January 2023. Real-world effectiveness for solid organ transplant (SOT) recipients has been unclear. Methods:...
8.
Joung S, Weber B, Wu M, Liu Y, Tang A, Driver M, et al.
BMC Infect Dis
. 2023 Feb;
23(1):97.
PMID: 36797666
Background: Individuals with post-acute sequelae of COVID (PASC) may have a persistence in immune activation that differentiates them from individuals who have recovered from COVID without clinical sequelae. To investigate...
9.
Ebinger J, Joung S, Wang M, Liu Y, Prostko J, Frias E, et al.
J Intern Med
. 2023 Jan;
293(4):520-523.
PMID: 36625223
No abstract available.
10.
Huang Y, Shin J, Xu A, Yao C, Joung S, Wu M, et al.
iScience
. 2022 Oct;
25(10):105209.
PMID: 36188190
SARS-CoV-2 vaccines have unquestionably blunted the overall impact of the COVID-19 pandemic, but host factors such as age, sex, obesity, and other co-morbidities can affect vaccine efficacy. We identified individuals...